Loss of Antigen Presentation in Adipose Tissue Macrophages or in Adipocytes, but Not Both, Improves Glucose Metabolism
- 15 April 2019
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 202 (8) , 2451-2459
Abstract
Macrophages, B cells, and adipocytes are among the adipose tissue (AT) APCs that differentiate and activate naive CD4+ T cells. Mice with adipocyte loss of MHC class II (MHC II) are more insulin sensitive. Because macrophages are professional APCs, mice with genetic myeloid MHC II depletion (myeloid MHC II knockout [mMHCII−/−]) were created and metabolically characterized. FITC+ glucan-coated particles (glucan-encapsulated small interfering RNA [siRNA] particles [GeRPs]) were also used to target MHC II knockout specifically in AT macrophages (ATMs). Mice with total body mMHCII−/− were generated by crossing LyzMCre with H2Ab1 floxed mice. For specific ATM depletion of H2Ab1, GeRPs containing H2Ab1 siRNA were administered to high-fat diet–fed C57BL/6 mice. Unexpectedly, mMHCII−/− mice had loss of both macrophage and adipocyte H2Ab1, one of only two Ag-presenting arms; thus, neither cell could present Ag and activate CD4+ T cells. This inability led to a reduction in AT immunosuppressive regulatory T cells, increased AT CD8+ T cells, and no improvement in systemic metabolism. Thus, with combined systemic myeloid and adipocyte MHC II loss, the impact of ATM-specific alterations in APC activity could not be delineated. Therefore, GeRPs containing H2Ab1 siRNA were administered to specifically reduce ATM H2Ab1 which, in contrast, revealed improved glucose tolerance. In conclusion, loss of either ATM or adipocyte APC function, but not both, improves systemic glucose metabolism because of maintenance of AT regulatory T cells. Key Points Loss of adipocyte and macrophage H2Ab1 leads to no change in metabolic phenotype. Specific loss of macrophage H2Ab1 leads to improvements in glucose tolerance. Adipocytes on HFD express LysM and are targeted by the LysMCre model.Keywords
This publication has 45 references indexed in Scilit:
- Improved Insulin Sensitivity despite Increased Visceral Adiposity in Mice Deficient for the Immune Cell Transcription Factor T-betCell Metabolism, 2013
- Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parametersNature Medicine, 2009
- Normalization of obesity-associated insulin resistance through immunotherapyNature Medicine, 2009
- Orally delivered siRNA targeting macrophage Map4k4 suppresses systemic inflammationNature, 2009
- Ablation of CD11c-Positive Cells Normalizes Insulin Sensitivity in Obese Insulin Resistant AnimalsCell Metabolism, 2008
- Adipose Macrophage Infiltration Is Associated With Insulin Resistance and Vascular Endothelial Dysfunction in Obese SubjectsArteriosclerosis, Thrombosis, and Vascular Biology, 2008
- Cause-Specific Excess Deaths Associated With Underweight, Overweight, and ObesityJAMA, 2007
- Macrophage PPARγ is required for normal skeletal muscle and hepatic insulin sensitivity and full antidiabetic effects of thiazolidinedionesJournal of Clinical Investigation, 2007
- Macrophage-specific PPARγ controls alternative activation and improves insulin resistanceNature, 2007
- CCR2 modulates inflammatory and metabolic effects of high-fat feedingJournal of Clinical Investigation, 2006